Venus Medtech (Hangzhou) Inc. (HKG:2500)
Hong Kong · Delayed Price · Currency is HKD 1.210
-0.020 (-1.63%)
May 29, 2026, 4:08 PM HKT
Venus Medtech (Hangzhou) Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -407.69 | -714.31 | -703.75 | -1,058 | -373.64 |
Depreciation & Amortization | 92.39 | 105.89 | 76.67 | 108.36 | 48.76 |
Other Amortization | 4.94 | 5.22 | 48.11 | 3.99 | 2.87 |
Loss (Gain) From Sale of Assets | 20.54 | -3.53 | 1.27 | 0.13 | 0.15 |
Asset Writedown & Restructuring Costs | - | 187.99 | 248.78 | 420.23 | 236.15 |
Loss (Gain) From Sale of Investments | 28.81 | 102.45 | -23.5 | 0.19 | 0.66 |
Loss (Gain) on Equity Investments | 2.1 | 4.15 | 12.38 | 13.94 | 11.71 |
Provision & Write-off of Bad Debts | - | - | - | 21.97 | 3.05 |
Other Operating Activities | 7.57 | 26.29 | -152.55 | -98.26 | -239.77 |
Change in Accounts Receivable | 101.83 | 90.95 | 14.21 | -7.85 | -74.13 |
Change in Inventory | -5.18 | -0.59 | -26.18 | -13.68 | -29.18 |
Change in Accounts Payable | -14.28 | 4.85 | 24.73 | 0.38 | 3.46 |
Change in Unearned Revenue | -0.72 | -27.96 | 26.25 | -12.92 | 0.29 |
Change in Other Net Operating Assets | -151.66 | 242.35 | -156.44 | -108.26 | -47.28 |
Operating Cash Flow | -321.35 | 23.74 | -610.02 | -729.46 | -456.92 |
Capital Expenditures | -10.76 | -33.92 | -260.64 | -169.98 | -82.07 |
Sale of Property, Plant & Equipment | 306.85 | 14.62 | 2.91 | 9.41 | - |
Cash Acquisitions | - | - | - | -813.49 | -124.59 |
Divestitures | - | -0.48 | - | - | 22.5 |
Sale (Purchase) of Intangibles | -0.01 | -7.64 | -2.27 | -8.79 | -19.71 |
Sale (Purchase) of Real Estate | 39.85 | - | - | - | -43.39 |
Investment in Securities | 25.52 | -0.43 | -26.01 | -98.17 | -416.78 |
Other Investing Activities | 2.62 | 7.95 | -60.85 | 4.76 | 15 |
Investing Cash Flow | 364.06 | -19.9 | -346.86 | -1,072 | -653.04 |
Long-Term Debt Issued | 185 | 104.03 | 413.48 | 939.14 | - |
Total Debt Issued | 185 | 104.03 | 413.48 | 939.14 | - |
Long-Term Debt Repaid | -346.13 | -563.26 | -543.81 | -237.46 | -20.25 |
Total Debt Repaid | -346.13 | -563.26 | -543.81 | -237.46 | -20.25 |
Net Debt Issued (Repaid) | -161.13 | -459.23 | -130.34 | 701.68 | -20.25 |
Issuance of Common Stock | - | - | - | - | 1,206 |
Repurchase of Common Stock | - | - | - | - | -72.55 |
Other Financing Activities | -22.93 | -28.11 | -43.65 | -66.55 | 278.31 |
Financing Cash Flow | -184.05 | -487.34 | -173.99 | 635.14 | 1,391 |
Foreign Exchange Rate Adjustments | 1.64 | 7.14 | 25.83 | 90.81 | -34.4 |
Net Cash Flow | -139.7 | -476.36 | -1,105 | -1,076 | 247.04 |
Free Cash Flow | -332.11 | -10.18 | -870.66 | -899.44 | -538.99 |
Free Cash Flow Margin | -108.25% | -2.16% | -177.19% | -221.28% | -129.61% |
Free Cash Flow Per Share | -0.76 | -0.02 | -1.99 | -2.05 | -1.23 |
Cash Interest Paid | 22.93 | 28.61 | 61.69 | 43.81 | 1.96 |
Cash Income Tax Paid | -0.06 | 0.95 | 3.44 | 3.07 | 8.65 |
Levered Free Cash Flow | -153.23 | 155.46 | -717.63 | -559.42 | -268.15 |
Unlevered Free Cash Flow | -142.1 | 165.86 | -678.43 | -531.53 | -266.96 |
Change in Working Capital | -70.01 | 309.59 | -117.43 | -142.32 | -146.85 |